Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-07-18
1989-08-15
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61U 3155
Patent
active
048575232
ABSTRACT:
The administration to an alcohol dependent of ibogaine, ibogaine HCl or other non-toxic salts of ibogaine, an alkaloid of the family apocynaceae, has been discovered to unexpectedly diminish the physiological and psychological aspect of the alcohol dependency syndrome. A single treatment will be effective for about 6 months. The treatments consisted of the oral administration of ibogaine or its salts in dosage ranges of 4 mg/kg to 25 mg/kg. The minimum effective dose was 400 mgs. and dosage increases above 1200 mgs. were found to be for the most part unnecessary.
REFERENCES:
patent: 2817623 (1957-12-01), Schneider
patent: 3557126 (1971-01-01), Sallay
patent: 4499096 (1985-02-01), Lolsof
patent: 4587243 (1986-05-01), Lolsol
E. C. Sonay, Substance Abuse Disorder in Clinical Practice, 1983, pp. 31-59.
B. Tabakof, P. B. Sutker, C. L. Randall, Medical and Social Aspects of Alcohol Abuse, 1983, pp. 187-220.
G. R. Baumgartner, R. C. Rowen, Clonidine vs. Chlordiazepoxide in the Management . . . , Arch. Intern. Medicine 147, 1987, pp. 1223-1226.
Friedman Stanley J.
Miskin Howard C.
NDA International, Inc.
LandOfFree
Rapid method for attenuating the alcohol dependency syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rapid method for attenuating the alcohol dependency syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapid method for attenuating the alcohol dependency syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-121823